Analysis of the expression of human tumor antigens in ovarian cancer tissues
- 1 January 2009
- journal article
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 6 (1) , 33-48
Abstract
Biomarkers for early detection of cancer have great clinical diagnostic potential. Numerous reports have documented the generation of humoral immune responses that are triggered in response to changes in protein expression patterns in tumor tissues and these biomarkers are referred to as tumor associated antigens (TAAs). Using a high-throughput technology, we previously identified 65 proteins as diagnostically useful TAAs by profiling the humoral immune responses in ovarian cancer (OVCA) patients. Here we determined the expression status of some of those TAAs in tissues from OVCA patients. The protein expression patterns of 4 of those 65 antigens, namely NASP, RCAS1, Nijmegen breakage syndrome1 (NBS1) and eIF5A, along with p53 and Her2 (known molecular prognosticators) and two proteins that interact with NBS1, MRE11 and RAD50, were assessed by immunohistochemistry (IHC). NASP and RCAS1 proteins were more frequently expressed in ovarian cancer tissues than with normal ovarian tissue and serous cystadenomas and MRE11 was less frequently expressed. When evaluated simultaneously, only NASP and MRE11 remained statistically significant with sensitivity of 66% and specificity of 89%. None of these proteins' expression levels were prognostic for survival. Together, our results indicate that occurrence of humoral immune responses against some of these TAAs in OVCA patients is triggered by antigen protein overexpression.Keywords
This publication has 48 references indexed in Scilit:
- Alternative isoform regulation in human tissue transcriptomesNature, 2008
- Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunityMolecular Cancer Therapeutics, 2008
- Increased expression of hypoxia-inducible factor 1α in type I and type II endometrial carcinomasLaboratory Investigation, 2007
- Nuclear Autoantigenic Sperm Protein (NASP), a Linker Histone Chaperone That Is Required for Cell ProliferationJournal of Biological Chemistry, 2006
- p53 autoantibodies predict subsequent development of cancerInternational Journal of Cancer, 2004
- Molecular Mechanism of the Recruitment of NBS1/hMRE11/hRAD50 Complex to DNA Double-strand Breaks: NBS1 Binds to γ-H2AX through FHA/BRCT DomainJournal of Radiation Research, 2004
- Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibilityJournal of Medical Genetics, 2003
- Characterization of the Histone H1-binding Protein, NASP, as a Cell Cycle-regulated Somatic ProteinJournal of Biological Chemistry, 2000
- Mechanisms underlying T-cell toleranceCurrent Opinion in Immunology, 1996
- Preoperative Serum CA-125 Levels in Patients With Surgical Stage I Invasive Ovarian AdenocarcinomaJNCI: Journal of the National Cancer Institute, 1988